Company intelligence / Profile preview

Northway Biotech

Ownership: Private
Employees: ~143
Development stage: Commercial

Overview

Northway Biotech does not have its own clinical results or drug candidates. It provides end-to-end contract development and manufacturing services from preclinical to commercial stages for global clients in the biopharmaceutical industry. The company has supported the scale-up of novel biologic drugs into cGMP manufacturing for clinical trials and commercialization.

Therapeutic areas: GastroenterologyDermatologyImmunology
Modalities: Protein-based biologics (including monoclonal antibodies and biosimilars)Gene therapiesRecombinant proteinsPlasmid DNA (pDNA)Fusion proteins
Industry: Drug Discovery Services

Partnerships

Mallia Therapeutics – process development & cGMP manufacture of sCD83 recombinant proteiniTolerance Inc. – CMC/manufacture of Streptavidin-FasL fusion protein supporting regenerative medicine/immunotolerance technology

Beyond the preview

Go deeper on Northway Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Northway Biotech.